Pharma Journalist - Page 24 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

China Approves Zai Lab’s AUGTYRO for NTRK Fusion Solid Tumors

FDA Issues Complete Response Letter for Outlook’s Wet AMD Therapy

Samsung Bioepis Begins Direct BYOOVIZ Commercialization in Europe

China Accepts BLA for Subcutaneous LEQEMBI Formulation

Insilico Medicine, Servier Partner on AI-Driven Oncology Drug Discovery

FDA Grants Priority Review for Tzield Pediatric Indication Expansion

Takeda, Protagonist File NDA for Rusfertide in Polycythemia Vera

Canada Approves Arrowhead’s REDEMPLO for Rare Triglyceride Disorder

Harbour BioMed, Bristol Myers Squibb Partner on Multi-Specific Antibodies

FDA Approves GSK’s Twice-Yearly Biologic for Severe Eosinophilic Asthma